Back to Search
Start Over
EFFICACY OF CENERIMOD IN PATIENTS WITH HIGH IFN-1 GENE EXPRESSION SIGNATURE AND HIGH ANTI-DSDNA ANTIBODY LEVELS: POST-HOC ANALYSIS FROM A PHASE 2 STUDY.
- Source :
- Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p903-904, 2p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 00034967
- Volume :
- 82
- Database :
- Complementary Index
- Journal :
- Annals of the Rheumatic Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 164385591
- Full Text :
- https://doi.org/10.1136/annrheumdis-2023-eular.3823